- Agreement encompasses an exclusive option on multiple targets over a two-year term, with potential to extend time and scope of the collaboration - “NBE-Therapeutics’ technology platforms give drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback